Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07066592
What this trial is testing

Investigation of the Effects of Prehabilitation Education Delivered Through a Mobile Compatible Website on Quality of Life and Symptoms in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological MalignancyPrehabilitationPatient Education
Saglik Bilimleri Universitesi 36
Testing effectiveness (Phase 2)Looking for participantsNCT06735495
What this trial is testing

CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors

Who this might be right for
B-Cell Lymphoblastic Leukemia/Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Early research (Phase 1)Study completedNCT03833180
What this trial is testing

Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaFollicular Lymphoma+9 more
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 91
Not applicableEnrolling By InvitationNCT07594496
What this trial is testing

Prevalence and Clinical Manifestations of Cannabis Withdrawal in Hospitalized Patients With Hematological Malignancies Undergoing Bone Marrow Transplant (BMT) or Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic 300
Testing effectiveness (Phase 2)Study completedNCT00841724
What this trial is testing

Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Nantes University Hospital 82
Testing effectiveness (Phase 2)Looking for participantsNCT07724873
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients

Who this might be right for
Hematopoietic Stem Cell Transplant (HSCT)GVHD - Graft-Versus-Host DiseaseHematological Malignancy
Tata Memorial Centre 54
Early research (Phase 1)Study completedNCT01213979
What this trial is testing

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Who this might be right for
Non-hematological Malignancies
Pharmacosmos A/S 16
Testing effectiveness (Phase 2)Ended earlyNCT02849886
What this trial is testing

T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

Who this might be right for
Graft Versus Host DiseaseHematological Malignancies
Centre Hospitalier Universitaire de Besancon 2
Early research (Phase 1)Ended earlyNCT04937166
What this trial is testing

Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Kahr Medical 25
Very early researchStudy completedNCT05895994
What this trial is testing

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Who this might be right for
NeoplasmsHematologic NeoplasmsNeoplasms by Site+1 more
MEI HENG 2
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Not applicableUnknownNCT02612402
What this trial is testing

Effect of Smartphone App on Activity

Who this might be right for
Diabetes Type 2Hematologic Malignancy
Rambam Health Care Campus 270
Testing effectiveness (Phase 2)Study completedNCT00445198
What this trial is testing

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Who this might be right for
Small Cell Lung CancerSmall Cell Lung Carcinoma
AbbVie (prior sponsor, Abbott) 86
Very early researchNot Yet RecruitingNCT07362602
What this trial is testing

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

Who this might be right for
Hematological Malignancies
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army 47
Not applicableNot Yet RecruitingNCT06992934
What this trial is testing

Immunological Impact of a Post Cell Therapy Treatment With FLT3 Inhibitors

Who this might be right for
Hematological Malignancies
Centre Hospitalier Universitaire de Nice 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07474961
What this trial is testing

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

Who this might be right for
Waldenstrom MacroglobulinaemiaMultiple Myeloma
Anne Louise Tølbøll Sørensen 400
Not applicableLooking for participantsNCT05259553
What this trial is testing

Biomarkers in Multiple Myeloma

Who this might be right for
Hematological PatientsNewly Diagnosed Multiple MyelomaChemotherapy
Centre Hospitalier Universitaire de Saint Etienne 70
Testing effectiveness (Phase 2)Study completedNCT00689000
What this trial is testing

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma
Chroma Therapeutics 57
Testing effectiveness (Phase 2)WithdrawnNCT02118311
What this trial is testing

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota
Next Page